Aligos Therapeutics (NASDAQ:ALGS - Get Free Report) is projected to release its earnings data before the market opens on Monday, March 10th. Analysts expect Aligos Therapeutics to post earnings of ($2.63) per share and revenue of $0.43 million for the quarter.
Aligos Therapeutics Stock Performance
Shares of ALGS traded down $0.54 during mid-day trading on Friday, reaching $12.94. 260,195 shares of the company's stock traded hands, compared to its average volume of 166,709. Aligos Therapeutics has a 12 month low of $6.76 and a 12 month high of $46.80. The stock has a market capitalization of $46.43 million, a P/E ratio of -0.97 and a beta of 2.52. The business's 50-day moving average price is $27.81 and its 200-day moving average price is $20.50.
Analyst Ratings Changes
Separately, HC Wainwright reiterated a "buy" rating and set a $75.00 price target on shares of Aligos Therapeutics in a research report on Thursday, November 7th.
Check Out Our Latest Report on Aligos Therapeutics
About Aligos Therapeutics
(
Get Free Report)
Aligos Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
See Also
Before you consider Aligos Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aligos Therapeutics wasn't on the list.
While Aligos Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
